Showing results (101-110 of 135) with videos related to
Sort By:
Pageof 14
Metabolism: Clinical and Experimental|February 15, 2001
Hyperinsulinemia in the physiologic range is not superior to short-term fasting in suppressing insulin secretion in obese menA I Pincelli, A Brunani, A Caumo, et al.Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Radial artery compliance in young, obese, normotensive subjectsA A Mangoni, C Giannattasio, A Brunani, et al.Hormone Research|January 1, 1991
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy studyM Moro, C Maraschini, P Toja, et al.Journal of Endocrinological Investigation|March 1, 1992
Evaluation of hypothalamic-pituitary function in patients with thalassemia majorL Danesi, M Scacchi, M De Martin, et al.European Review for Medical and Pharmacological Sciences|January 3, 2013
Percutaneous transluminal angioplasty improves glucose control and quality of life in patients with critical limb ischemiaV S Tolva, R Casana, L Lonati, et al.Hormone Research|August 18, 2001
The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistanceA I Pincelli, A Brunani, M Scacchi, et al.Gynecologic and Obstetric Investigation|January 1, 1984
Metergoline in the management of normoprolactinemic secondary amenorrhea. A multicentric controlled trialR Fadini, M Meschia, P G Crosignani, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 2, 1998
Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese womenM Tagliaferri, M Scacchi, A I Pincelli, et al.The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemiaA R Genazzani, F Cavagnini, G B Picotti, et al.The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humansE Ghigo, L Gianotti, E Arvat, et al.Pageof 14